Contract Services Clinical Research
Telix Pharmaceuticals Applauds CMS Proposed Changes to Improve Payments for Diagnostic Radiopharmaceuticals
Telix Pharmaceuticals welcomes proposed changes announced by the Centers for Medicare & Medicaid Services (CMS) for the Hospital Outpatient Prospective...
July 11, 2024 | News
Thermo Fisher Scientific Opens First Electron Microscopy Demo Center in Taiwan to Propel Semiconductor Innovation
To support next-generation semiconductor and materials innovation, Thermo Fisher Scientific today announced the opening of its first electron microscopy de...
July 10, 2024 | News
Sirnaomics Announces Positive Interim Results for Phase I Clinical Study of RNAi Therapeutic STP122G Targeting Factor XI
Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engagin...
July 09, 2024 | News
BioCity Biopharma's SC0062 Achieves Primary Endpoint in Phase 2 CKD Trial, Demonstrates Significant Proteinuria Reduction
BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reducti...
July 09, 2024 | News
Zhejiang Doer Biologics Completes Enrollment for Phase 1b/2a Trial of DR10624 in Obese Subjects with Hypertriglyceridemia
Zhejiang Doer Biologics, a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announc...
July 08, 2024 | News
Hinova Pharmaceuticals Secures FDA Fast Track Designation for HP518 in Treating AR+ Triple-Negative Breast Cancer
Hinova Pharmaceuticals a leading biopharmaceutical company dedicated to developing innovative cancer therapies, today announced that the U.S. Food an...
July 08, 2024 | News
XPOVIO® Secures NMPA Approval for Treatment of R/R DLBCL in China, Expanding Its Indications
- Following its initial approval for the treatment of relapsed/refractory multiple myeloma (R/R MM), XPOVIO® has now received approval as a monoth...
July 08, 2024 | News
Ascentage Pharma Secures $100 Million Option Payment from Takeda for Third-Generation BCR-ABL Inhibitor
Ascentage Pharma a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies ...
July 04, 2024 | News
MEDIPAL and JCR Pharmaceuticals Announce Regulatory Review Completion for Phase I/II Trial of JR-446 in Treating Ultra-Rare Sanfilippo Syndrome Type B
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced the completion of the regulatory review by the Pharmaceuticals an...
July 03, 2024 | News
N-Power Medicine Partners with MSD to Expand Oncologist and Patient Access to Clinical Trials
N-Power Medicine, a company reinventing the clinical trial process, is collaborating with Merck, known as MSD outside the United States and Canada, to enab...
July 02, 2024 | News
Lilly Forms Strategic Partnership with Radionetics for GPCR-Targeted Radiopharmaceuticals
Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals Radionetics to receive $140 million upfront p...
July 02, 2024 | News
HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries
Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...
July 02, 2024 | News
Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability
Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...
July 01, 2024 | News
Thermo Fisher Scientific Expands Kentucky Operations with $47.8 Million Investment
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced the expansion of its central labo...
June 28, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
